Catalight Practice G
Catalight Practice Guidelines Reflect a Contemporary Research View of the Dosage Effect and Outcome Measures in Autism Care
April 23, 2024 17:28 ET | Catalight
WALNUT CREEK, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Catalight, one of the largest behavioral health networks in the United States working to support individuals with autism and intellectual and...
2022_CAI_Logo_Blue.png
Huntington Bancshares Incorporated Hires Three Neurodiverse Teams Fulltime in Technology with CAI Neurodiverse Solutions
April 17, 2024 09:00 ET | CAI
CAI today announced that Huntington Bank hired three teams of neurodivergent individuals fulltime through CAI Neurodiverse Solutions.
PaxMedica logo.jpg
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
April 11, 2024 16:30 ET | PaxMedica, Inc.
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
PaxMedica logo.jpg
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
March 13, 2024 08:20 ET | PaxMedica, Inc.
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
Horizontal-Logo-Tagline Lockup-onWhitebkd-01 (6)[31].png
BlueSprig Pediatrics Sponsors Armani Williams Ahead of the Daytona ARCA 200
February 12, 2024 09:00 ET | BlueSprig Pediatrics, Inc.
DAYTONA BEACH, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Blue Sprig Pediatrics, Inc. (BlueSprig), a leader in Applied Behavior Analysis (ABA) therapy for children diagnosed with Autism Spectrum...
Stalilcla logo.png
Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements
January 16, 2024 06:00 ET | STALICLA
Geneva, Switzerland, January 16th, 2024 – Stalicla SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders, announces the...
Xolv
Xolv Creates a New Venture to Embark on New Era of Innovation in Behavioral Health
January 03, 2024 16:53 ET | Xolv
WALNUT CREEK, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Xolv, formerly Catalight’s IT and technology innovation group, proudly announces its transition to a new corporation today as part of a...
NeuroQure Logo.png
NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
December 13, 2023 09:30 ET | NeuroQure
IRVINE, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the...
Autism Spectrum Disorder Treatment Market Globenewswire
Autism Spectrum Disorder Treatment Market Size to Surpass USD 13.14 Billion by 2030, exhibiting a CAGR of 8.5%
November 27, 2023 06:14 ET | Fortune Business Insights
Pune, India, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The autism spectrum disorder treatment market size was valued at USD 6.94 billion in 2022, and it is anticipated to expand from USD 7.41 billion in...
Lindsey Sneed
Study: Autistic Children May Need Fewer Hours of Treatment Than Previously Thought
November 21, 2023 13:41 ET | Catalight
Walnut Creek, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Each year, tens of thousands of parents and caregivers of children with autism spectrum disorder (ASD) face vital decisions: What kind of...